Signaling Pathways - angiogenesis - Prostanoid Receptors - Glutamate (Metabotropic) Group I Receptors - EZH2
清除全部
- B5532 NPS 2390Target: Glutamate (Metabotropic) Group I ReceptorsSummary: I型mGlu拮抗剂
- B6569 CHPGTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: mGlu5代谢型谷氨酸受体激动剂
- B7568 16,16-Dimethyl Prostaglandin E2Target: Prostanoid ReceptorsSummary: 前列腺素E2的衍生物
- B7088 L-161,982Target: Prostanoid ReceptorsSummary: EP4受体拮抗剂
- B4678 CPI-1691 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- B1583 UNC19992 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- A3633 MPEP HydrochlorideTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: MGlu5受体拮抗剂
- A3449 GSK3431 CitationTarget: EZH2Summary: EZH2抑制剂
- A3446 GSK1265 CitationTarget: EZH2Summary: EZH2抑制剂
- A4211 Lenalidomide (CC-5013)中文名: 来那度胺Target: angiogenesisSummary: 抗肿瘤药物,抑制血管生成。